<< Back New York biotech company takes massive loss in selloff of CBD unit 87 0 System Admin / Thursday, December 7, 2023 / Categories: HempToday.net New York-based 22nd Century Group said it intends to sell off its GVB Biopharma unit, a CBD maker, with the price tag estimated at $2.25 million – after having purchased … New York biotech company takes massive loss in selloff of CBD unit Read More » Print 0Upvote 0Downvote Tags CBDInvestmentNewsNorth AmericaUSACompaniesTransactions Related articles South Carolina bans CBD and intoxicating hemp products as states continue crackdowns Ahead for the industry: Fiber and food, sure, but hemp will be relegated to a ‘specialty crop’ German hemp company says it will diversify into vape device sales U.S. CBD company inks sponsorship deal with professional baseball league Hempcrete seen as part of eco-friendly solution to Zimbabwe’s housing shortage << Back